rxstatShortages › Timolol Travoprost

Timolol Travoprost shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Timolol Travoprost products are in shortage in Canada (1 of 2 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 4, 2026.
Products affected
1 / 2
In shortage since
Oct 8, 2025
Est. full return
Sep 4, 2026
Reports on file
11
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-TRAVOPROST-TIMOP PQ
0.5% 0.004% · SOLUTION · APOTEX INC
DIN 02415305 · since Oct 8, 2025, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Resolved
DUOTRAV PQ
0.5% 0.004% · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02278251 · ended Jun 1, 2026 · Demand increase for the drug.
Resolved
DUOTRAV PQ
0.004% 0.5% · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02278251 · ended Feb 27, 2026 · Demand increase for the drug.
Resolved
APO-TRAVOPROST-TIMOP PQ
0.5% 0.004% · SOLUTION · APOTEX INC
DIN 02415305 · ended Aug 11, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-TRAVOPROST-TIMOP PQ
0.5% 0.004% · SOLUTION · APOTEX INC
DIN 02415305 · ended Jul 12, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-TRAVOPROST-TIMOP PQ
0.004% 0.5% · SOLUTION · APOTEX INC
DIN 02415305 · ended Mar 30, 2022 · Disruption of the manufacture of the drug.
Resolved
APO-TRAVOPROST-TIMOP PQ
0.004% 0.5% · SOLUTION · APOTEX INC
DIN 02415305 · ended Oct 30, 2020 · Disruption of the manufacture of the drug.
Resolved
APO-TRAVOPROST-TIMOP
0.5% 0.004% · SOLUTION · APOTEX INC
DIN 02415305 · ended Mar 3, 2020 · Disruption of the manufacture of the drug.
Resolved
DUOTRAV PQ
0.5% 0.004% · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02278251 · ended Feb 25, 2020 · Delay in shipping of the drug.
Resolved
DUOTRAV PQ
0.5% 0.004% · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02278251 · ended Dec 24, 2019 · Disruption of the manufacture of the drug.
Resolved
DUOTRAV PQ
0.5% 0.004% · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02278251 · ended Feb 27, 2018 · Delay in shipping of the drug.

What's happening

Timolol Travoprost is currently affected by an active shortage report filed with Health Canada by APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Timolol Travoprost is classified under “ANTIGLAUCOMA PREPARATIONS AND MIOTICS” (ATC S01ED).

Recent changes

Common questions

When will Timolol Travoprost be back in stock in Canada?

The latest manufacturer estimate is Sep 4, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Timolol Travoprost in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiglaucoma preparations and miotics)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.